Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | NAAA | Q02083 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | STS | P08842 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.32 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.32 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16086282 | 0.88 | CYP2C19 (0.48) | CYP2C19EPHX1CA1CA2CA12 | |
| SCHEMBL16086283 | 0.82 | CYP2C19 (0.44) | CYP2C19EPHX1CA1CA2CA12 | |
| SCHEMBL5493739 | 0.82 | CYP2C19 (0.52) | CYP2C19EPHX1CA1CA2CA12 | |
| SCHEMBL16086274 | 0.82 | CYP2C19 (0.47) | CYP2C19EPHX1CA1CA2CA12 | |
| SCHEMBL9485096 | 0.82 | CYP2C19 (0.52) | CYP2C19EPHX1CA1CA2CA12 | |
| SCHEMBL16086398 | 0.77 | CYP2C19 (0.47) | CYP2C19EPHX1CA1CA2CA12 | |
| SCHEMBL16086650 | 0.77 | CYP2C19 (0.47) | CYP2C19EPHX1CA1CA2CA12 | |
| SCHEMBL16086275 | 0.77 | CYP2C19 (0.43) | CYP2C19EPHX1CA1CA2CA12 | |
| SCHEMBL3781529 | 0.74 | CYP2C19 (0.49) | CYP2C19EPHX1CA1CA2CA12 | |
| SCHEMBL26276749 | 0.74 | CYP2C19 (0.44) | CYP2C19EPHX1CA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7919133-B2 | Substituted cyclopropanecarboxylic acid (3-methyl-cyclohexyl)amide as flavoring substance | SYMRISE GMBH & CO. KG (DE) | 2011-04-05 | — | — | US | disclosed |
| US-20080292763-A1 | Substituted Cyclopropanecarboxylic acid (3-methyl-cyclohexyl)amide as flavoring substance | SYMRISE GMBH & CO. KG (DE) | 2008-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080292763-A1 | Substituted Cyclopropanecarboxylic acid (3-methyl-cyclohexyl)amide as flavoring substance | TAS1R1, TAS2R1, TAS1R3 | CYP2C19 692/4885EPHX1 1402/4885CA1 375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.